Stabicon Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.70 Cr
as on 17-07-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.08 Cr
as on 17-07-2024
- Revenue -34.11%
(FY 2023)
- Profit -591.12%
(FY 2023)
- Ebitda -129.36%
(FY 2023)
- Net Worth -28.34%
(FY 2023)
- Total Assets 3.37%
(FY 2023)
About Stabicon Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.70 Cr.
The company currently has active open charges totaling ₹4.08 Cr.
Palaniandy Krishnamurthy and Kushboo Ranka serve as directors at the Company.
- CIN/LLPIN
U73100KA2010PTC052428
- Company No.
052428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stabicon Life Sciences Private Limited offer?
Stabicon Life Sciences Private Limited offers a wide range of products and services, including IT, Networking & Automation Solution, IT Solutions, Material Testing Labs & Services, Testing Services, Product Engineering and Prototyping, Product Engineering Service, Pharma & Bioanalytical Services, Pharmaceutical Services, Medical Consultants & Clinics, Medical Consultancy Services.
Who are the key members and board of directors at Stabicon Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palaniandy Krishnamurthy  | Director | 04-May-2021 | Current |
| Kushboo Ranka | Director | 12-Feb-2010 | Current |
Financial Performance of Stabicon Life Sciences.
Stabicon Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.11% decrease. The company also saw a substantial fall in profitability, with a 591.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stabicon Life Sciences?
In 2023, Stabicon Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2020 | ₹2.79 M | Open |
State Bank Of India Creation Date: 28 Feb 2011 | ₹3.80 Cr | Open |
How Many Employees Work at Stabicon Life Sciences?
Stabicon Life Sciences has a workforce of 75 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stabicon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stabicon Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
